The PE Ratio as of December 2024 (TTM) for Arcutis Biotherapeutics, Inc. (ARQT) is -8.98

According to Arcutis Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.98. This represents a change of 68.48% compared to the average of -5.33 of the last 4 quarters.

Arcutis Biotherapeutics, Inc. (ARQT) Historical PE Ratio (quarterly & annually)

How has ARQT PE Ratio performed in the past?

The mean historical PE Ratio of Arcutis Biotherapeutics, Inc. over the last ten years is -33.61. The current -8.98 PE Ratio has changed 2.57% with respect to the historical average. Over the past ten years (40 quarters), ARQT's PE Ratio was at its highest in in the December 2023 quarter at -1.13. The PE Ratio was at its lowest in in the March 2018 quarter at -66.06.

Arcutis Biotherapeutics, Inc. (ARQT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Arcutis Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arcutis Biotherapeutics, Inc. (ARQT) Average PE Ratio

How has ARQT PE Ratio performed in the past?

The current PE Ratio of Arcutis Biotherapeutics, Inc. (ARQT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Arcutis Biotherapeutics, Inc. (ARQT) PE Ratio vs. Peers

How is ARQT’s PE Ratio compared to its peers?

Arcutis Biotherapeutics, Inc.’s PE Ratio is less than Terns Pharmaceuticals, Inc. (-5.12), less than Amylyx Pharmaceuticals, Inc. (-1.05), less than Acumen Pharmaceuticals, Inc. (-1.32), less than Inozyme Pharma, Inc. (-1.92), less than X4 Pharmaceuticals, Inc. (-6.95), greater than Icosavax, Inc. (-15.78), greater than Mirum Pharmaceuticals, Inc. (-20.71), less than VectivBio Holding AG (-7.94), greater than Day One Biopharmaceuticals, Inc. (-14.52), greater than Mirati Therapeutics, Inc. (-11.26), greater than Apellis Pharmaceuticals, Inc. (-16.51), less than Spero Therapeutics, Inc. (17.30), less than Bolt Biotherapeutics, Inc. (-0.30), greater than Coherus BioSciences, Inc. (-376.35), greater than Gracell Biotechnologies Inc. (-29.26), less than Neoleukin Therapeutics, Inc. (-5.86), less than Theseus Pharmaceuticals, Inc. (-6.29), less than Monte Rosa Therapeutics, Inc. (-4.84), less than Design Therapeutics, Inc. (-7.53), less than Erasca, Inc. (-4.56),

Build a custom stock screener for Arcutis Biotherapeutics, Inc. (ARQT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcutis Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcutis Biotherapeutics, Inc. (ARQT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcutis Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.